Brief: BioLife Solutions Q2 Revenue USD 39.5 Million Vs. IBES Estimate USD 43.9 Million
08/08/2023 21:03
Aug 08 (Reuters) - BioLife Solutions Q2 gross margin 28%. * Q2 adjusted gross margin 35% * outlook FY revenue USD 144-158 million
Recent news on BioLife Solutions
See all newsFreshworks gains ahead of S&P SmallCap 600 inclusion
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: S&P Dow Jones Indices Freshworks Set To Join S&P Smallcap 600
BioLife Solutions, Inc. reports results for the quarter ended June 30 - Earnings Summary